Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identified the novel resistant biomarkers for taxane-based therapy for triple-negative breast cancer

1 Jan 2021

Abstract excerpt

Developing treatment strategies for triple-negative breast cancer (TNBC) has become an important clinical challenge. Currently, taxane-based chemotherapy is one of the standard treatments for TNBC. However, determining the key factor of taxane-resistance is urgently in need for clinical treatment for breast cancer. We used GEO data to generate paclitaxel resistance in two basal-like TNBC cell lines (SUM149 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Treatment and Pharmacology
Share to Computational Drug Discovery Methods
Share to HER2/EGFR in Cancer Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34104083
DOI: 10.7150/ijms.59177

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identified the novel resistant biomarkers for taxane-based therapy for triple-negative breast cancerPMID 34104083Read ↗

Construction and Identification of a Novel 5-Gene Signature for Predicting the Prognosis in Breast CancerSemantic proximity Read ↗

Exploring the resistance mechanism of triple-negative breast cancer to paclitaxel through the scRNA-seq analysisSemantic proximity Read ↗

Transcriptomic Analysis of Breast Cancer Patients Sensitive and Resistant to Chemotherapy: Looking for Overall Survival and Drug Resistance BiomarkersSemantic proximity Read ↗

Identification of Key Genes Potentially Related to Triple Receptor Negative Breast Cancer by Microarray AnalysisSemantic proximity Read ↗

Transcriptomic analysis of breast cancer patients sensitive and resistant to chemotherapy: Looking for overall survival and drug resistance biomarkersSemantic proximity Read ↗

Identification of Seven Hub Genes as the Novel Biomarkers in Triple-negative Breast Cancer and Breast Cancer MetastasisSemantic proximity Read ↗

Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision MedicineSemantic proximity Read ↗

KEGG-expressed genes and pathways in triple negative breast cancerSemantic proximity Read ↗

Identification of Personalized Chemoresistance Genes in Subtypes of Basal-Like Breast Cancer Based on Functional Differences Using Pathway AnalysisSemantic proximity Read ↗

Network-based Approach to Identify Prognosis-related Genes in Tamoxifen-treated Patients With Estrogen Receptor-positive Breast CancerSemantic proximity Read ↗

Identification of hub genes affecting triple-negative breast cancer using bioinformatics analysis strategiesSemantic proximity Read ↗

Identification of Hub Genes and Key Pathways Associated with Anti-VEGF Resistant Glioblastoma Using Gene Expression Data AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.